IP Library Granted Patent US 8,356,594
Granted Patent B2
US 8,356,594 · App. 12/613,035 · Granted Jan 22, 2013

Methods and apparatus for heart failure treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,356,594
App. No.
12/613,035
Granted
Jan 22, 2013
Kind
B2
Abstract

Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Treatment of obstruction due to reflex vocal cord closure often experienced by heart failure patients is distinguished from treatment of upper airway obstruction typically associated with Obstructive Sleep Disorder Treatment may also be implemented by delivering synchronized cardiac pressure oscillations superimposed on a respiratory pressure level to provide assistance for the heart. Heart treatment pressure dose indicator may be calculated for prescribing and monitoring the delivery of treatment. The apparatus may also generate data to track heart failure condition that may be indicative of the degree of severity of heart failure based upon breathing patterns to assist in the diagnosis and management of heart failure patients.

Claims (24)

1. A method for controlling setting of a positive air pressure treatment regime for a patient comprising:

detecting an obstruction event from an airflow signal attributable to any one of vocal cord closure and upper airway obstruction of a patient,

determining, with a processor, a sleep stage attributable to the patient,

differentiating, with the processor, between an event of vocal cord closure and upper airway obstruction based on the sleep stage of the patient, and

selecting a treatment regime based on the differentiating.

2. A method for applying positive air pressure to a patient in accordance with claim 1 , wherein the detecting the obstruction event comprises measuring the patient's minute volume and comparing the measured minute volume to a threshold value.

3. A method for applying positive air pressure to a patient in accordance with claim 1 , wherein the processor determines an early stage of sleep if ventilation has been applied for less than about 30 minutes, and determines a later stage of sleep if ventilation has been applied for more than about 30 minutes.

4. A method for applying positive air pressure to a patient in accordance with claim 3 , wherein the processor maintains or decreases the air pressure if the patient is in an early stage of sleep, and wherein the processor increases the air pressure if the patient is in a later stage of sleep.

5. A method for applying positive air pressure to a patient in accordance with claim 1 further including detecting at least one of Cheyne-Stokes breathing and central apneas, and in response thereto delivering variations in pressure in phase with the patient's respiration to meet a target ventilation.

6. The method of claim 1 , wherein the upper airway obstruction includes at least one of tongue closure and soft palate closure.

7. The method of claim 1 , wherein the detection of the obstruction event comprises a detection of a decrease in the volume of airflow over a period of time.

8. An apparatus for controlling a setting of positive air pressure for a patient comprising:

a blower configured to provide positive air pressure to a patient; and

a processor configured to:

detect an obstruction event from an airflow signal attributable to any one of vocal cord closure and upper airway obstruction in a patient;

determine a sleep stage attributable to the patient;

differentiate between the vocal cord closure and the upper airway obstruction based on the sleep stage of the patient; and

select a treatment regime based on the differentiating.

9. The apparatus of claim 8 , wherein the processor is configured to detect the obstruction event by measuring the patient's minute volume and comparing the measured minute volume to a threshold value.

10. The apparatus of claim 8 , wherein the processor is configured to determine an early stage of sleep if ventilation has been applied for less than about 30 minutes, and to determine a later stage of sleep if ventilation has been applied for more than about 30 minutes.

11. The apparatus of claim 10 , wherein the processor is configured to select one treatment regime that maintains or decreases the air pressure if the patient is in an early stage of sleep, and selects another treatment regime that increases the air pressure if the patient is in a later stage of sleep.

12. The apparatus of claim 8 , wherein the processor is configured to detect at least one of Cheyne-Stokes breathing and central apneas, and in response thereto deliver variations in pressure in phase with the patient's respiration to meet a target ventilation.

13. The apparatus of claim 8 , wherein the upper airway obstruction includes at least one of tongue closure and soft palate closure.

14. The apparatus of claim 8 , wherein the processor is configured to detect an obstruction event by detecting a decrease in the volume of airflow over a period of time.

Assignments (3)
CHANGE OF NAME Recorded Jun 6, 2019
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 049454/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2012
From: RESMED (R&D) LIMITED
To: RESMED LIMITED
Reel/Frame 029280/0592 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2012
From: UJHAZY, ANTHONY JOHN; WRIGHT, JONATHAN CALDWELL; RICHARDS, GLENN; BASSIN, DAVID JOHN; BERTHON-JONES, MICHAEL
To: RESMED (R&D) LIMITED
Reel/Frame 029237/0410 →